It’s unsettling to realize that our usually long bout of unhappiness is actually clinical depression.
It just gets worse once we learn that all the current medications offered to treat it aren’t effective. Even though some are fortunate enough to find relief from their depressive symptoms using medications like Prozac and Wellbutrin, the overwhelming majority still don’t find them helpful. Clearly, diagnosing and treating depression effectively requires that we revisit our original interpretation, which suggests that it’s solely the result of a chemical imbalance of serotonin or norepinephrine.
Everyone describes their depression differently, but the underlying issue is usually the same: suffering from a persistent struggle to simply live and enjoy life. According to one report, some of the most common symptoms include:
Apathy or volatility
Sadness & hopelessness
Anxiety & restlessness
Insomnia or hypersomnia
These symptoms, while unpleasant, do not point to anything biological. Rather, they point to something more psychological. Therefore, new depression treatments should offer patients the opportunity to experience short periods of time without the constant reminders of their depressive symptoms, even if they can’t remove them completely.
Thankfully, this is where low dose IV ketamine has proven to be most useful. In the last decade, medical practitioners and researchers alike have found it to be more effective as an antidepressant for most patients with depression, PTSD, bi-polar disorder and the like. So, what does ketamine work when other depression treatments fail? Research suggests that the therapeutic value of treatment as an antidepressant lies in the mild dissociative effects that it produces. Also, a cycle of ketamine infusions for depression was shown to be most effective as a complementary treatment to traditional SSRI’s and SNRI’s.
While typical MBCT works as effectively as an antidepressant medication, it is still less accessible for those who don’t live near large cities. MBB is easily accessible online, narrowing the cost of travel and eliminating long wait times to see a psychologist. Overall, MMB is a highly viable option to help those who need care quicker and at a lower-cost than in-person therapy.
As research continues, the FDA will likely continue to approve more ketamine-based drugs for depression. This is good news since it follows that more insurance companies will likely cover patient treatments. Until then, we encourage anyone struggling to maintain their mental wellness to reach out to our clinic (630-300-0469) to learn about our depression treatment options.
Contact Renew Ketamine
Renew Ketamine is Chicagoland’s leading provider of ketamine infusions for depression and pain. Contact us today for a free consultation and find out if you or a loved one is a candidate for ketamine infusion therapy.
